These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 26087631)
1. [Specific features of hypertension in patients with systemic lupus erythematosus]. Savina ZE; Shilkina NP Ter Arkh; 2015; 87(4):30-35. PubMed ID: 26087631 [TBL] [Abstract][Full Text] [Related]
2. [Brachial artery responsiveness in patients with systemic lupus erythematosus and scleroderma systematica]. Vinogradov AA; Shilkina NP; Kostyreva NA Ter Arkh; 2010; 82(1):43-6. PubMed ID: 20364700 [TBL] [Abstract][Full Text] [Related]
3. Traditional risk factor assessment does not capture the extent of cardiovascular risk in systemic lupus erythematosus. Lee AB; Godfrey T; Rowley KG; Karschimkus CS; Dragicevic G; Romas E; Clemens L; Wilson AM; Nikpour M; Prior DL; Best JD; Jenkins AJ Intern Med J; 2006 Apr; 36(4):237-43. PubMed ID: 16640741 [TBL] [Abstract][Full Text] [Related]
4. [Functional state of the vessel endothelium in patients with systemic lupus erythematosis]. Shevchuk SV; Stanislavchuk MA Lik Sprava; 2006 Dec; (8):39-45. PubMed ID: 17427423 [TBL] [Abstract][Full Text] [Related]
5. Systemic lupus erythematosus: an independent risk factor for endothelial dysfunction in women. El-Magadmi M; Bodill H; Ahmad Y; Durrington PN; Mackness M; Walker M; Bernstein RM; Bruce IN Circulation; 2004 Jul; 110(4):399-404. PubMed ID: 15262847 [TBL] [Abstract][Full Text] [Related]
6. Reduced flow-mediated vasodilation as a marker for cardiovascular complications in lupus patients. Kiss E; Soltesz P; Der H; Kocsis Z; Tarr T; Bhattoa H; Shoenfeld Y; Szegedi G J Autoimmun; 2006 Dec; 27(4):211-7. PubMed ID: 17088047 [TBL] [Abstract][Full Text] [Related]
7. Traditional and non-traditional risk factors contribute to the development of accelerated atherosclerosis in patients with systemic lupus erythematosus. de Leeuw K; Freire B; Smit AJ; Bootsma H; Kallenberg CG; Bijl M Lupus; 2006; 15(10):675-82. PubMed ID: 17120595 [TBL] [Abstract][Full Text] [Related]
8. Lumbar spine bone mineral density predicts endothelial reactivity in patients with systemic lupus erythematosus. Mak A; Ling LH; Ho RC; Gong L; Cheak AA; Yee H; Vasoo S; Koh DR; Robless PA Clin Exp Rheumatol; 2011; 29(2):261-8. PubMed ID: 21385541 [TBL] [Abstract][Full Text] [Related]
9. [Arterial hypertension in patients with systemic connective tissue diseases and hemorrhagic vasculitis]. Shilkina NP; Iunonin IE; Stoliarova SA; Driazhenkova IV Ter Arkh; 2010; 82(5):40-5. PubMed ID: 20597269 [TBL] [Abstract][Full Text] [Related]
10. [Risk factors of thickened intima-media and atherosclerotic plaque development in carotid arteries in patients with systemic lupus erythematosus]. Fischer K Ann Acad Med Stetin; 2008; 54(2):22-32. PubMed ID: 19374227 [TBL] [Abstract][Full Text] [Related]
11. Subclinical atherosclerosis in systemic lupus erythematosus and antiphospholipid syndrome: focus on β2GPI-specific T cell response. Conti F; Spinelli FR; Alessandri C; Pacelli M; Ceccarelli F; Marocchi E; Montali A; Capozzi A; Buttari B; Profumo E; Sorice M; Arca M; Valesini G; Riganò R Arterioscler Thromb Vasc Biol; 2014 Mar; 34(3):661-8. PubMed ID: 24436371 [TBL] [Abstract][Full Text] [Related]
12. Coronary, Carotid, and Lower-extremity Atherosclerosis and Their Interrelationship in Danish Patients with Systemic Lupus Erythematosus. Kay SD; Poulsen MK; Diederichsen AC; Voss A J Rheumatol; 2016 Feb; 43(2):315-22. PubMed ID: 26628595 [TBL] [Abstract][Full Text] [Related]
13. Endothelium-dependent but not endothelium-independent flow-mediated dilation is significantly reduced in patients with systemic lupus erythematosus without vascular events: a metaanalysis and metaregression. Mak A; Liu Y; Ho RC J Rheumatol; 2011 Jul; 38(7):1296-303. PubMed ID: 21459950 [TBL] [Abstract][Full Text] [Related]
14. Circulating endothelial cells as a marker of vascular dysfunction in patients with systemic lupus erythematosus by real-time polymerase chain reaction. Attia FM; Maaty A; Kalil FA Arch Pathol Lab Med; 2011 Nov; 135(11):1482-5. PubMed ID: 22032577 [TBL] [Abstract][Full Text] [Related]
15. Human recombinant relaxin-2 does not attenuate hypertension or renal injury but exacerbates vascular dysfunction in a female mouse model of SLE. Wolf VL; Phillips TL; Taylor EB; Sasser JM; Ryan MJ Am J Physiol Heart Circ Physiol; 2019 Aug; 317(2):H234-H242. PubMed ID: 31125285 [TBL] [Abstract][Full Text] [Related]
16. Nighttime Blood Pressure Patterns and Subclinical Atherosclerosis in Women with Systemic Lupus Erythematosus. Sabio JM; Martinez-Bordonado J; Sánchez-Berná I; Vargas-Hitos JA; Mediavilla JD; Navarrete-Navarrete N; Zamora-Pasadas M; Ruíz ME; Jiménez-Alonso J J Rheumatol; 2015 Dec; 42(12):2310-7. PubMed ID: 26568596 [TBL] [Abstract][Full Text] [Related]
17. Vasculitis in systemic lupus erythematosus (SLE)--assessment of peripheral blood mononuclear cell activation and the degree of endothelial dysfunction: initial report. Kluz J; Kopeć W; Jakobsche U; Prajs I; Adamiec R Postepy Hig Med Dosw (Online); 2007 Dec; 61():725-35. PubMed ID: 18063917 [TBL] [Abstract][Full Text] [Related]
18. Atorvastatin therapy improves endothelial-dependent vasodilation in patients with systemic lupus erythematosus: an 8 weeks controlled trial. Ferreira GA; Navarro TP; Telles RW; Andrade LE; Sato EI Rheumatology (Oxford); 2007 Oct; 46(10):1560-5. PubMed ID: 17693444 [TBL] [Abstract][Full Text] [Related]
19. Brachial endothelial function is impaired in patients with systemic lupus erythematosus. Lima DS; Sato EI; Lima VC; Miranda F; Hatta FH J Rheumatol; 2002 Feb; 29(2):292-7. PubMed ID: 11842823 [TBL] [Abstract][Full Text] [Related]
20. Hypertension and impaired vascular function in a female mouse model of systemic lupus erythematosus. Ryan MJ; McLemore GR Am J Physiol Regul Integr Comp Physiol; 2007 Feb; 292(2):R736-42. PubMed ID: 16971374 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]